Editorials - The treatment options for localized prostate cancer

Research output: Contribution to journalReview articlepeer-review


Prostate cancer is a very common tumor in men. Today the disease is very often diagnosed early because of an elevated PSA without symptoms and the disease is localized to the prostate. Patients with prostate cancer can be divided into 3 subgroups for the carcinoma: favorable, moderate, and poorly. The grouping depends mainly on the Gleason score of the prostate biopsy. According to the Gleason score, favorable cancer is up to score 6 (3+3), moderate - score 7, and poor - Gleason score 8-10. The other favorable clinical factors are PSA < 10 ng/ml, and clinical stage by DRE of T1C or T2 (no nodule or palpable nodule not extending beyond the prostatic capsule). The treatment options for cure when the prostate cancer is localized are either radical prostatectomy or radiotherapy (external or brachytherapy or combination). Each of these therapies has side effects and each has advantages and disadvantages. Sometimes the treatment choice is not for cure and the options are hormonal treatment or watchful waiting. Twenty to 30% of the patients treated for cure may fail the treatment and have elevation of PSA without any clinical symptoms, or signs of local recurrence or distant spread. Some of these patients with biochemical failure may be cured by salvage treatment: radiotherapy after radical prostatectomy and salvage radical prostatectomy or cryotherapy following failure of radiotherapy.

Original languageEnglish
Pages (from-to)36-37
Number of pages2
Issue number1 SPEC. ISS.
StatePublished - Jan 2006


  • Brachytherapy
  • External radiation
  • PSA
  • Prostate cancer
  • Radical prostatectomy


Dive into the research topics of 'Editorials - The treatment options for localized prostate cancer'. Together they form a unique fingerprint.

Cite this